Methods and compositions for treating symptoms associated with post-traumatic stress disorder using cyclobenzaprine
US9918948B2 · kind B2 · utility
10Cited by
52References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 18, 2010 |
| Grant date | Mar 20, 2018 |
| Priority date | — |
| Expiry date | Nov 18, 2030 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/22
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to methods for the treatment or prevention of symptoms associated with post-traumatic stress disorder, and related pharmaceutical compositions. Of particular interest are pharmaceutical compositions comprising a very low dose of cyclobenzaprine, alone, or in combination with an alpha-1-adrenergic receptor antagonist, a beta-adrenergic antagonist, an anticonvulsant, a selective serotonin reuptake inhibitor or a serotonin-norepinephrine reuptake inhibitor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.